TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novavax AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
73,932
|
141,170
|
95,913 |
Financial expenses |
61,294
|
69,397
|
41,934 |
Earnings before taxes |
17,565
|
46,565
|
-10,909 |
EBITDA |
20,167
|
48,255
|
-9,826 |
Total assets |
325,859
|
336,782
|
351,398 |
Current assets |
18,521
|
237,002
|
251,164 |
Current liabilities |
118,866
|
149,274
|
203,418 |
Equity capital |
206,993
|
187,508
|
147,980 |
- share capital |
5
|
4
|
5 |
Employees (average) |
195
|
167
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.5%
|
55.7%
|
42.1% |
Turnover per employee |
379
|
845 | |
Profit as a percentage of turnover |
23.8%
|
33.0%
|
-11.4% |
Return on assets (ROA) |
24.2%
|
34.4%
|
8.8% |
Current ratio |
15.6%
|
158.8%
|
123.5% |
Return on equity (ROE) |
8.5%
|
24.8%
|
-7.4% |
Change turnover |
-67,650
|
53,027
|
57,272 |
Change turnover % |
-48%
|
60%
|
148% |
Chg. No. of employees |
28
|
167
|
-57 |
Chg. No. of employees % | 17% | -100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.